Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.

Anaerobe

Gonzales-Luna AJ, Spinler JK, Oezguen N, Khan MAW, Danhof HA, Endres BT, Alam MJ, Begum K, Lancaster C, Costa GP, Savidge TC, Hurdle JG, Britton R, Garey KW.
PMID: 34044101
Anaerobe. 2021 Aug;70:102387. doi: 10.1016/j.anaerobe.2021.102387. Epub 2021 May 24.

BACKGROUND: Fecal microbiota transplantation (FMT) aims to cure Clostridioides difficile infection (CDI) through reestablishing a healthy microbiome and restoring colonization resistance. Although often effective after one infusion, patients with continued microbiome disruptions may require multiple FMTs. In this N-of-1...

Cite
Gonzales-Luna AJ, Spinler JK, Oezguen N, et al. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation. Anaerobe. 2021;70:102387doi: 10.1016/j.anaerobe.2021.102387.
Gonzales-Luna, A. J., Spinler, J. K., Oezguen, N., Khan, M. A. W., Danhof, H. A., Endres, B. T., Alam, M. J., Begum, K., Lancaster, C., Costa, G. P., Savidge, T. C., Hurdle, J. G., Britton, R., & Garey, K. W. (2021). Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation. Anaerobe, 70102387. https://doi.org/10.1016/j.anaerobe.2021.102387
Gonzales-Luna, Anne J, et al. "Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation." Anaerobe vol. 70 (2021): 102387. doi: https://doi.org/10.1016/j.anaerobe.2021.102387
Gonzales-Luna AJ, Spinler JK, Oezguen N, Khan MAW, Danhof HA, Endres BT, Alam MJ, Begum K, Lancaster C, Costa GP, Savidge TC, Hurdle JG, Britton R, Garey KW. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation. Anaerobe. 2021 Aug;70:102387. doi: 10.1016/j.anaerobe.2021.102387. Epub 2021 May 24. PMID: 34044101; PMCID: PMC8384661.
Copy Download .nbib Format: NLM
Corticosteroids Do Not Increase the Likelihood of Primary .

Open forum infectious diseases

Carlson TJ, Gonzales-Luna AJ, Wilcox MF, Theriault SG, Alnezary FS, Patel P, Ahn BK, Zasowski EJ, Garey KW.
PMID: 34646906
Open Forum Infect Dis. 2021 Aug 11;8(10):ofab419. doi: 10.1093/ofid/ofab419. eCollection 2021 Oct.

BACKGROUND: The pathogenesis of METHODS: This was a case-control study of hospitalized adults. The case population included patients diagnosed with primary CDI who received at least 1 dose of a high-risk antibiotic (cefepime, meropenem, or piperacillin-tazobactam) in the 90...

Cite
Carlson TJ, Gonzales-Luna AJ, Wilcox MF, et al. Corticosteroids Do Not Increase the Likelihood of Primary . Open Forum Infect Dis. 2021;8(10):ofab419doi: 10.1093/ofid/ofab419.
Carlson, T. J., Gonzales-Luna, A. J., Wilcox, M. F., Theriault, S. G., Alnezary, F. S., Patel, P., Ahn, B. K., Zasowski, E. J., & Garey, K. W. (2021). Corticosteroids Do Not Increase the Likelihood of Primary . Open forum infectious diseases, 8(10), ofab419. https://doi.org/10.1093/ofid/ofab419
Carlson, Travis J, et al. "Corticosteroids Do Not Increase the Likelihood of Primary ." Open forum infectious diseases vol. 8,10 (2021): ofab419. doi: https://doi.org/10.1093/ofid/ofab419
Carlson TJ, Gonzales-Luna AJ, Wilcox MF, Theriault SG, Alnezary FS, Patel P, Ahn BK, Zasowski EJ, Garey KW. Corticosteroids Do Not Increase the Likelihood of Primary . Open Forum Infect Dis. 2021 Aug 11;8(10):ofab419. doi: 10.1093/ofid/ofab419. eCollection 2021 Oct. PMID: 34646906; PMCID: PMC8501294.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Clostridioides difficile Ribotype 255 Strain Mta-79, Assembled Using Oxford Nanopore and Illumina Sequencing.

Microbiology resource announcements

Spinler JK, Gonzales-Luna AJ, Raza S, Runge JK, Luna RA, Savidge TC, Garey KW.
PMID: 31624167
Microbiol Resour Announc. 2019 Oct 17;8(42). doi: 10.1128/MRA.00935-19.

Hybrid

Cite
Spinler JK, Gonzales-Luna AJ, Raza S, et al. Complete Genome Sequence of Clostridioides difficile Ribotype 255 Strain Mta-79, Assembled Using Oxford Nanopore and Illumina Sequencing. Microbiol Resour Announc. 2019;8(42)doi: 10.1128/MRA.00935-19.
Spinler, J. K., Gonzales-Luna, A. J., Raza, S., Runge, J. K., Luna, R. A., Savidge, T. C., & Garey, K. W. (2019). Complete Genome Sequence of Clostridioides difficile Ribotype 255 Strain Mta-79, Assembled Using Oxford Nanopore and Illumina Sequencing. Microbiology resource announcements, 8(42), . https://doi.org/10.1128/MRA.00935-19
Spinler, Jennifer K, et al. "Complete Genome Sequence of Clostridioides difficile Ribotype 255 Strain Mta-79, Assembled Using Oxford Nanopore and Illumina Sequencing." Microbiology resource announcements vol. 8,42 (2019). doi: https://doi.org/10.1128/MRA.00935-19
Spinler JK, Gonzales-Luna AJ, Raza S, Runge JK, Luna RA, Savidge TC, Garey KW. Complete Genome Sequence of Clostridioides difficile Ribotype 255 Strain Mta-79, Assembled Using Oxford Nanopore and Illumina Sequencing. Microbiol Resour Announc. 2019 Oct 17;8(42). doi: 10.1128/MRA.00935-19. PMID: 31624167; PMCID: PMC6797532.
Copy Download .nbib Format: NLM
Epidemic .

Open forum infectious diseases

Endres BT, Begum K, Sun H, Walk ST, Memariani A, Lancaster C, Gonzales-Luna AJ, Dotson KM, Bassères E, Offiong C, Tupy S, Kuper K, Septimus E, Arafat R, Alam MJ, Zhao Z, Hurdle JG, Savidge TC, Garey KW.
PMID: 30793006
Open Forum Infect Dis. 2019 Feb 09;6(2):ofz013. doi: 10.1093/ofid/ofz013. eCollection 2019 Feb.

No abstract available.

Cite
Endres BT, Begum K, Sun H, et al. Epidemic . Open Forum Infect Dis. 2019;6(2):ofz013doi: 10.1093/ofid/ofz013.
Endres, B. T., Begum, K., Sun, H., Walk, S. T., Memariani, A., Lancaster, C., Gonzales-Luna, A. J., Dotson, K. M., Bassères, E., Offiong, C., Tupy, S., Kuper, K., Septimus, E., Arafat, R., Alam, M. J., Zhao, Z., Hurdle, J. G., Savidge, T. C., & Garey, K. W. (2019). Epidemic . Open forum infectious diseases, 6(2), ofz013. https://doi.org/10.1093/ofid/ofz013
Endres, Bradley T, et al. "Epidemic ." Open forum infectious diseases vol. 6,2 (2019): ofz013. doi: https://doi.org/10.1093/ofid/ofz013
Endres BT, Begum K, Sun H, Walk ST, Memariani A, Lancaster C, Gonzales-Luna AJ, Dotson KM, Bassères E, Offiong C, Tupy S, Kuper K, Septimus E, Arafat R, Alam MJ, Zhao Z, Hurdle JG, Savidge TC, Garey KW. Epidemic . Open Forum Infect Dis. 2019 Feb 09;6(2):ofz013. doi: 10.1093/ofid/ofz013. eCollection 2019 Feb. PMID: 30793006; PMCID: PMC6368847.
Copy Download .nbib Format: NLM
Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.

Anaerobe

Almutairi MS, Gonzales-Luna AJ, Alnezary FS, Fallatah SB, Alam MJ, Begum K, Garey KW.
PMID: 34461273
Anaerobe. 2021 Aug 27;72:102440. doi: 10.1016/j.anaerobe.2021.102440. Epub 2021 Aug 27.

BACKGROUND: Although Clostridioides difficile surveillance often identifies emerging strains, clinical outcome evaluations are rarely performed. Ribotype (RT) 106 is a commonly isolated C. difficile strain worldwide; however, studies investigating RT 106 clinical outcomes are limited. The purpose of this...

Cite
Almutairi MS, Gonzales-Luna AJ, Alnezary FS, et al. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021;72:102440doi: 10.1016/j.anaerobe.2021.102440.
Almutairi, M. S., Gonzales-Luna, A. J., Alnezary, F. S., Fallatah, S. B., Alam, M. J., Begum, K., & Garey, K. W. (2021). Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe, 72102440. https://doi.org/10.1016/j.anaerobe.2021.102440
Almutairi, Masaad Saeed, et al. "Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains." Anaerobe vol. 72 (2021): 102440. doi: https://doi.org/10.1016/j.anaerobe.2021.102440
Almutairi MS, Gonzales-Luna AJ, Alnezary FS, Fallatah SB, Alam MJ, Begum K, Garey KW. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021 Aug 27;72:102440. doi: 10.1016/j.anaerobe.2021.102440. Epub 2021 Aug 27. PMID: 34461273.
Copy Download .nbib Format: NLM
Miocardiopatía inducida por arritmia: informe de caso.

Archivos de cardiologia de Mexico

Gonzales-Luna AC, Segura-Saldaña P, León-Vivar R, Laurente-Gómez J, Ríos-Navarro P.
PMID: 34310582
Arch Cardiol Mex. 2021;91(3):379-382. doi: 10.24875/ACM.200002521.

No abstract available.

Cite
Gonzales-Luna AC, Segura-Saldaña P, León-Vivar R, et al. Arrhythmia-induced cardiomyopathy: case report. Miocardiopatía inducida por arritmia: informe de caso. Arch Cardiol Mex. 2021;91(3):379-382doi: 10.24875/ACM.200002521.
Gonzales-Luna, A. C., Segura-Saldaña, P., León-Vivar, R., Laurente-Gómez, J., & Ríos-Navarro, P. (2021). Arrhythmia-induced cardiomyopathy: case report. Miocardiopatía inducida por arritmia: informe de caso. Archivos de cardiologia de Mexico, 91(3), 379-382. https://doi.org/10.24875/ACM.200002521
Gonzales-Luna, Ana C, et al. "Arrhythmia-induced cardiomyopathy: case report." Miocardiopatía inducida por arritmia: informe de caso. Archivos de cardiologia de Mexico vol. 91,3 (2021): 379-382. doi: https://doi.org/10.24875/ACM.200002521
Gonzales-Luna AC, Segura-Saldaña P, León-Vivar R, Laurente-Gómez J, Ríos-Navarro P. Arrhythmia-induced cardiomyopathy: case report. Miocardiopatía inducida por arritmia: informe de caso. Arch Cardiol Mex. 2021;91(3):379-382. doi: 10.24875/ACM.200002521. PMID: 34310582; PMCID: PMC8351661.
Copy Download .nbib Format: NLM
Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With .

Open forum infectious diseases

Carlson TJ, Endres BT, Le Pham J, Gonzales-Luna AJ, Alnezary FS, Nebo K, Miranda J, Lancaster C, Bassères E, Begum K, Alam MJ, Reveles KR, Garey KW.
PMID: 31993458
Open Forum Infect Dis. 2020 Jan 04;7(1):ofz552. doi: 10.1093/ofid/ofz552. eCollection 2020 Jan.

BACKGROUND: Patients with METHODS: This multicenter, retrospective cohort study included adult patients with CDI of known ribotypes stratified by eosinopenia, defined as an absence of eosinophils in the peripheral blood (Houston cohort). The primary outcome was inpatient mortality. Results...

Cite
Carlson TJ, Endres BT, Le Pham J, et al. Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With . Open Forum Infect Dis. 2020;7(1):ofz552doi: 10.1093/ofid/ofz552.
Carlson, T. J., Endres, B. T., Le Pham, J., Gonzales-Luna, A. J., Alnezary, F. S., Nebo, K., Miranda, J., Lancaster, C., Bassères, E., Begum, K., Alam, M. J., Reveles, K. R., & Garey, K. W. (2020). Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With . Open forum infectious diseases, 7(1), ofz552. https://doi.org/10.1093/ofid/ofz552
Carlson, Travis J, et al. "Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With ." Open forum infectious diseases vol. 7,1 (2020): ofz552. doi: https://doi.org/10.1093/ofid/ofz552
Carlson TJ, Endres BT, Le Pham J, Gonzales-Luna AJ, Alnezary FS, Nebo K, Miranda J, Lancaster C, Bassères E, Begum K, Alam MJ, Reveles KR, Garey KW. Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With . Open Forum Infect Dis. 2020 Jan 04;7(1):ofz552. doi: 10.1093/ofid/ofz552. eCollection 2020 Jan. PMID: 31993458; PMCID: PMC6979314.
Copy Download .nbib Format: NLM
Impact of COVID-19 on pacemaker implant.

Journal of arrhythmia

Gonzales-Luna AC, Torres-Valencia JO, Alarcón-Santos JE, Segura-Saldaña PA.
PMID: 32837668
J Arrhythm. 2020 Jul 23; doi: 10.1002/joa3.12411. Epub 2020 Jul 23.

OBJECTIVES: The purpose of this article was to determine the change in the volume of pacemaker implantations with the COVID-2019 pandemic and to assess the change in the number of pacemaker implants according to etiology during the pandemic.BACKGROUND: The...

Cite
Gonzales-Luna AC, Torres-Valencia JO, Alarcón-Santos JE, et al. Impact of COVID-19 on pacemaker implant. J Arrhythm. 2020;doi: 10.1002/joa3.12411.
Gonzales-Luna, A. C., Torres-Valencia, J. O., Alarcón-Santos, J. E., & Segura-Saldaña, P. A. (2020). Impact of COVID-19 on pacemaker implant. Journal of arrhythmia, . https://doi.org/10.1002/joa3.12411
Gonzales-Luna, Ana C, et al. "Impact of COVID-19 on pacemaker implant." Journal of arrhythmia vol. (2020). doi: https://doi.org/10.1002/joa3.12411
Gonzales-Luna AC, Torres-Valencia JO, Alarcón-Santos JE, Segura-Saldaña PA. Impact of COVID-19 on pacemaker implant. J Arrhythm. 2020 Jul 23; doi: 10.1002/joa3.12411. Epub 2020 Jul 23. PMID: 32837668; PMCID: PMC7404435.
Copy Download .nbib Format: NLM
Significant Publications on Infectious Diseases Pharmacotherapy in 2020.

Journal of pharmacy practice

Eubank TA, Zaidan N, Alnezary FS, Moc C, Olson K, Zaki A, McDaneld PM, Gonzales-Luna AJ.
PMID: 34449277
J Pharm Pract. 2021 Aug 27;8971900211040438. doi: 10.1177/08971900211040438. Epub 2021 Aug 27.

No abstract available.

Cite
Eubank TA, Zaidan N, Alnezary FS, et al. Significant Publications on Infectious Diseases Pharmacotherapy in 2020. J Pharm Pract. 2021;8971900211040438doi: 10.1177/08971900211040438.
Eubank, T. A., Zaidan, N., Alnezary, F. S., Moc, C., Olson, K., Zaki, A., McDaneld, P. M., Gonzales-Luna, A. J. (2021). Significant Publications on Infectious Diseases Pharmacotherapy in 2020. Journal of pharmacy practice, 8971900211040438. https://doi.org/10.1177/08971900211040438
Eubank, Taryn A, et al. "Significant Publications on Infectious Diseases Pharmacotherapy in 2020." Journal of pharmacy practice vol. (2021): 8971900211040438. doi: https://doi.org/10.1177/08971900211040438
Eubank TA, Zaidan N, Alnezary FS, Moc C, Olson K, Zaki A, McDaneld PM, Gonzales-Luna AJ. Significant Publications on Infectious Diseases Pharmacotherapy in 2020. J Pharm Pract. 2021 Aug 27;8971900211040438. doi: 10.1177/08971900211040438. Epub 2021 Aug 27. PMID: 34449277.
Copy Download .nbib Format: NLM
Assessment of Kidney Injury as a Severity Criteria for .

Open forum infectious diseases

Carlson TJ, Gonzales-Luna AJ, Nebo K, Chan HY, Tran NT, Antony S, Lancaster C, Alam MJ, Begum K, Garey KW.
PMID: 33209956
Open Forum Infect Dis. 2020 Oct 07;7(11):ofaa476. doi: 10.1093/ofid/ofaa476. eCollection 2020 Nov.

BACKGROUND: The Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) revised their METHODS: This multicenter cohort study included adult hospitalized patients with CDI. Patients were assessed for the presence of acute kidney injury...

Cite
Carlson TJ, Gonzales-Luna AJ, Nebo K, et al. Assessment of Kidney Injury as a Severity Criteria for . Open Forum Infect Dis. 2020;7(11):ofaa476doi: 10.1093/ofid/ofaa476.
Carlson, T. J., Gonzales-Luna, A. J., Nebo, K., Chan, H. Y., Tran, N. T., Antony, S., Lancaster, C., Alam, M. J., Begum, K., & Garey, K. W. (2020). Assessment of Kidney Injury as a Severity Criteria for . Open forum infectious diseases, 7(11), ofaa476. https://doi.org/10.1093/ofid/ofaa476
Carlson, Travis J, et al. "Assessment of Kidney Injury as a Severity Criteria for ." Open forum infectious diseases vol. 7,11 (2020): ofaa476. doi: https://doi.org/10.1093/ofid/ofaa476
Carlson TJ, Gonzales-Luna AJ, Nebo K, Chan HY, Tran NT, Antony S, Lancaster C, Alam MJ, Begum K, Garey KW. Assessment of Kidney Injury as a Severity Criteria for . Open Forum Infect Dis. 2020 Oct 07;7(11):ofaa476. doi: 10.1093/ofid/ofaa476. eCollection 2020 Nov. PMID: 33209956; PMCID: PMC7652094.
Copy Download .nbib Format: NLM
Humoral Immune Response to .

Open forum infectious diseases

Alonso CD, Papamichael K, Sprague R, Barrett C, Gonzales-Luna AJ, Daugherty K, Garey KW, Villafuerte-Gálvez J, Xu H, Lin Q, Wang L, Chen X, Pollock NR, Kelly CP.
PMID: 34258317
Open Forum Infect Dis. 2021 Jun 01;8(7):ofab286. doi: 10.1093/ofid/ofab286. eCollection 2021 Jul.

BACKGROUND: The humoral immune response to METHODS: We conducted a prospective study of hospitalized adults with CDI, with and without immunosuppression (hematologic malignancy, active solid tumor, solid organ or stem cell transplant, inflammatory bowel disease, autoimmune disease, congenital or...

Cite
Alonso CD, Papamichael K, Sprague R, et al. Humoral Immune Response to . Open Forum Infect Dis. 2021;8(7):ofab286doi: 10.1093/ofid/ofab286.
Alonso, C. D., Papamichael, K., Sprague, R., Barrett, C., Gonzales-Luna, A. J., Daugherty, K., Garey, K. W., Villafuerte-Gálvez, J., Xu, H., Lin, Q., Wang, L., Chen, X., Pollock, N. R., & Kelly, C. P. (2021). Humoral Immune Response to . Open forum infectious diseases, 8(7), ofab286. https://doi.org/10.1093/ofid/ofab286
Alonso, Carolyn D, et al. "Humoral Immune Response to ." Open forum infectious diseases vol. 8,7 (2021): ofab286. doi: https://doi.org/10.1093/ofid/ofab286
Alonso CD, Papamichael K, Sprague R, Barrett C, Gonzales-Luna AJ, Daugherty K, Garey KW, Villafuerte-Gálvez J, Xu H, Lin Q, Wang L, Chen X, Pollock NR, Kelly CP. Humoral Immune Response to . Open Forum Infect Dis. 2021 Jun 01;8(7):ofab286. doi: 10.1093/ofid/ofab286. eCollection 2021 Jul. PMID: 34258317; PMCID: PMC8271131.
Copy Download .nbib Format: NLM
Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.

Anaerobe

Almutairi MS, Gonzales-Luna AJ, Alnezary FS, Fallatah SB, Alam MJ, Begum K, Garey KW.
PMID: 34461273
Anaerobe. 2021 Dec;72:102440. doi: 10.1016/j.anaerobe.2021.102440. Epub 2021 Aug 27.

BACKGROUND: Although Clostridioides difficile surveillance often identifies emerging strains, clinical outcome evaluations are rarely performed. Ribotype (RT) 106 is a commonly isolated C. difficile strain worldwide; however, studies investigating RT 106 clinical outcomes are limited. The purpose of this...

Cite
Almutairi MS, Gonzales-Luna AJ, Alnezary FS, et al. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021;72:102440doi: 10.1016/j.anaerobe.2021.102440.
Almutairi, M. S., Gonzales-Luna, A. J., Alnezary, F. S., Fallatah, S. B., Alam, M. J., Begum, K., & Garey, K. W. (2021). Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe, 72102440. https://doi.org/10.1016/j.anaerobe.2021.102440
Almutairi, Masaad Saeed, et al. "Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains." Anaerobe vol. 72 (2021): 102440. doi: https://doi.org/10.1016/j.anaerobe.2021.102440
Almutairi MS, Gonzales-Luna AJ, Alnezary FS, Fallatah SB, Alam MJ, Begum K, Garey KW. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021 Dec;72:102440. doi: 10.1016/j.anaerobe.2021.102440. Epub 2021 Aug 27. PMID: 34461273.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries